In SERVE‐HF, patients were randomised to receive optimal medical therapy for HF (Ponikowski et al., 2016 (link)) alone, or in combination with ASV (Auto Set CS, ResMed). Full details of ASV titration and settings have been reported previously (Cowie et al., 2015 (link)).